Exagen Appoints Wendy Johnson to Board of Directors
23 sept. 2020 16h10 HE
|
Exagen Inc.
SAN DIEGO, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, is proud to...
Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)
21 sept. 2020 08h25 HE
|
Exagen Inc.
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
03 sept. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
“My Disease May Be Invisible, But I’m Not”: Patients Tell Their Stories During September’s Rheumatic Disease Awareness Month
02 sept. 2020 11h29 HE
|
American College of Rheumatology
ATLANTA, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) and Simple Tasks™ will recognize the fifth annual Rheumatic Disease Awareness Month (RDAM) this September with...
Rheumatoid Arthritis Therapeutics Market to Reach USD 33,958.4 Million by 2025 | Global Market Size, Share, Analysis, Growth, Forecast [2018-2025]
20 août 2020 06h34 HE
|
Fortune Business Insights
Pune, Aug. 20, 2020 (GLOBE NEWSWIRE) -- According to the report, the global rheumatoid arthritis therapeutics market is anticipated to exhibit 4.6% CAGR and reach valuation of US$ 33,958.4 Mn in...
Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome
03 août 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen to Present at the Canaccord Genuity 40th Annual Growth Conference
30 juil. 2020 16h25 HE
|
Exagen Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis
29 juil. 2020 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that data from a first-in-human pilot trial that evaluated its proprietary Vagus Nerve Stimulation (VNS)...
Exagen Inc. Reports Second Quarter 2020 Results
28 juil. 2020 07h00 HE
|
Exagen Inc.
Testing Experiencing Monthly Sequential ImprovementRecord Gross Margins of 63% SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming...
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
27 juil. 2020 16h05 HE
|
Exagen Inc.
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...